Association between cannabis laws and opioid prescriptions among privately insured adults in the US

Mukaila Raji, N. Ogechi Abara, Habeeb Salameh, Jordan R. Westra, Yong Fang Kuo

Research output: Contribution to journalArticle

Abstract

We examine the association between opioid prescription patterns in privately insured adults and changes in state cannabis laws among five age groups (18–25, 26–35 36–45, 46–55 and 56–64 years). Using the 2016 Clinformatics Data Mart, a nationwide commercial health insurance database, we performed a cross-sectional analysis of two types of opioid prescribing (>30-day and >90-day prescriptions) among all adults aged 18–64 based on the stringency of cannabis laws. We found a significant interaction between age and cannabis law on opioid prescriptions. Age-stratified multilevel multivariable analyses showed lower opioid prescription rates in the four younger age groups only in states with medical cannabis laws, when considering both >30 day and >90 day opioid use [>30 day adjusted odds ratio (aOR) = 0.56, in 18–25, aOR = 0.67 in 26–35, aOR = 0.67 in 36–45, and aOR = 0.76 in 46–54 years; >90 day aOR = 0.56, in 18–25, aOR = 0.68 in 26–35, aOR = 0.69 in 36–45, and aOR = 0.77 in 46–54 years, P < 0.0001 for all]. This association was not significant in the oldest age group of 55–64 years. There was no significant association between opioid prescriptions and other categories of cannabis laws (recreational use and decriminalization) in any of the age groups studied.

Original languageEnglish (US)
Pages (from-to)62-68
Number of pages7
JournalPreventive Medicine
Volume125
DOIs
StatePublished - Aug 1 2019

Fingerprint

Cannabis
Opioid Analgesics
Prescriptions
Odds Ratio
Age Groups
Medical Marijuana
Multilevel Analysis
Health Insurance
Cross-Sectional Studies
Databases

Keywords

  • Cannabis
  • Commercial insurance
  • Cross-sectional
  • Marijuana
  • Medical cannabis
  • Opioid
  • Prescription

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Association between cannabis laws and opioid prescriptions among privately insured adults in the US. / Raji, Mukaila; Abara, N. Ogechi; Salameh, Habeeb; Westra, Jordan R.; Kuo, Yong Fang.

In: Preventive Medicine, Vol. 125, 01.08.2019, p. 62-68.

Research output: Contribution to journalArticle

@article{39a77e26f4af4cf0b73a441409a4214c,
title = "Association between cannabis laws and opioid prescriptions among privately insured adults in the US",
abstract = "We examine the association between opioid prescription patterns in privately insured adults and changes in state cannabis laws among five age groups (18–25, 26–35 36–45, 46–55 and 56–64 years). Using the 2016 Clinformatics Data Mart, a nationwide commercial health insurance database, we performed a cross-sectional analysis of two types of opioid prescribing (>30-day and >90-day prescriptions) among all adults aged 18–64 based on the stringency of cannabis laws. We found a significant interaction between age and cannabis law on opioid prescriptions. Age-stratified multilevel multivariable analyses showed lower opioid prescription rates in the four younger age groups only in states with medical cannabis laws, when considering both >30 day and >90 day opioid use [>30 day adjusted odds ratio (aOR) = 0.56, in 18–25, aOR = 0.67 in 26–35, aOR = 0.67 in 36–45, and aOR = 0.76 in 46–54 years; >90 day aOR = 0.56, in 18–25, aOR = 0.68 in 26–35, aOR = 0.69 in 36–45, and aOR = 0.77 in 46–54 years, P < 0.0001 for all]. This association was not significant in the oldest age group of 55–64 years. There was no significant association between opioid prescriptions and other categories of cannabis laws (recreational use and decriminalization) in any of the age groups studied.",
keywords = "Cannabis, Commercial insurance, Cross-sectional, Marijuana, Medical cannabis, Opioid, Prescription",
author = "Mukaila Raji and Abara, {N. Ogechi} and Habeeb Salameh and Westra, {Jordan R.} and Kuo, {Yong Fang}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.ypmed.2019.05.012",
language = "English (US)",
volume = "125",
pages = "62--68",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Association between cannabis laws and opioid prescriptions among privately insured adults in the US

AU - Raji, Mukaila

AU - Abara, N. Ogechi

AU - Salameh, Habeeb

AU - Westra, Jordan R.

AU - Kuo, Yong Fang

PY - 2019/8/1

Y1 - 2019/8/1

N2 - We examine the association between opioid prescription patterns in privately insured adults and changes in state cannabis laws among five age groups (18–25, 26–35 36–45, 46–55 and 56–64 years). Using the 2016 Clinformatics Data Mart, a nationwide commercial health insurance database, we performed a cross-sectional analysis of two types of opioid prescribing (>30-day and >90-day prescriptions) among all adults aged 18–64 based on the stringency of cannabis laws. We found a significant interaction between age and cannabis law on opioid prescriptions. Age-stratified multilevel multivariable analyses showed lower opioid prescription rates in the four younger age groups only in states with medical cannabis laws, when considering both >30 day and >90 day opioid use [>30 day adjusted odds ratio (aOR) = 0.56, in 18–25, aOR = 0.67 in 26–35, aOR = 0.67 in 36–45, and aOR = 0.76 in 46–54 years; >90 day aOR = 0.56, in 18–25, aOR = 0.68 in 26–35, aOR = 0.69 in 36–45, and aOR = 0.77 in 46–54 years, P < 0.0001 for all]. This association was not significant in the oldest age group of 55–64 years. There was no significant association between opioid prescriptions and other categories of cannabis laws (recreational use and decriminalization) in any of the age groups studied.

AB - We examine the association between opioid prescription patterns in privately insured adults and changes in state cannabis laws among five age groups (18–25, 26–35 36–45, 46–55 and 56–64 years). Using the 2016 Clinformatics Data Mart, a nationwide commercial health insurance database, we performed a cross-sectional analysis of two types of opioid prescribing (>30-day and >90-day prescriptions) among all adults aged 18–64 based on the stringency of cannabis laws. We found a significant interaction between age and cannabis law on opioid prescriptions. Age-stratified multilevel multivariable analyses showed lower opioid prescription rates in the four younger age groups only in states with medical cannabis laws, when considering both >30 day and >90 day opioid use [>30 day adjusted odds ratio (aOR) = 0.56, in 18–25, aOR = 0.67 in 26–35, aOR = 0.67 in 36–45, and aOR = 0.76 in 46–54 years; >90 day aOR = 0.56, in 18–25, aOR = 0.68 in 26–35, aOR = 0.69 in 36–45, and aOR = 0.77 in 46–54 years, P < 0.0001 for all]. This association was not significant in the oldest age group of 55–64 years. There was no significant association between opioid prescriptions and other categories of cannabis laws (recreational use and decriminalization) in any of the age groups studied.

KW - Cannabis

KW - Commercial insurance

KW - Cross-sectional

KW - Marijuana

KW - Medical cannabis

KW - Opioid

KW - Prescription

UR - http://www.scopus.com/inward/record.url?scp=85066295718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066295718&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2019.05.012

DO - 10.1016/j.ypmed.2019.05.012

M3 - Article

C2 - 31125629

AN - SCOPUS:85066295718

VL - 125

SP - 62

EP - 68

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -